pharmacor tacrolimus tacrolimus 1 mg capsule bottle
pharmacor pty ltd - tacrolimus monohydrate -
tacrolimus 0.5mg hard capsule
pharm v solutions limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tacrolimus - hard capsule - tacrolimus - immunosuppressants
tacrolimus 1mg hard capsule
pharm v solutions limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tacrolimus - hard capsule - tacrolimus 1 mg - immunosuppressants
tacrolimus 5mg hard capsule
pharm v solutions limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tacrolimus - hard capsule - tacrolimus 5 mg - immunosuppressants
tacrolimus 0.5mg capsules hard
accord healthcare limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tacrolimus - hard capsule - tacrolimus - immunosuppressants
tacrolimus 1mg capsules hard
accord healthcare limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tacrolimus - hard capsule - tacrolimus 1 mg - immunosuppressants
tacrolimus 5mg hard capsules
accord healthcare limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tacrolimus - hard capsule - tacrolimus 5 mg - immunosuppressants
tacrolimus ointment
glenmark pharmaceuticals inc., usa - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). tacrolimus ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.
tacrolimus ointment
accord healthcare inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). tacrolimus ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.
tacrolimus capsule
kaiser foundation hospitals - tacrolimus (unii: wm0haq4wnm) (anhydrous tacrolimus - unii:y5l2157c4j) - tacrolimus 1 mg